We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 1.50 | 1.40 | 1.60 | 1.50 | 1.50 | 1.50 | 33,133 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.29 | 2.03M |
Date | Subject | Author | Discuss |
---|---|---|---|
27/2/2018 19:55 | PW, that could have gone either way as we both know - I threw it out their as I had to disappear for a while but clearly 'lost' on this occasion ;o). | wossupsa | |
27/2/2018 17:43 | Pwhite????? | spacedust | |
27/2/2018 17:31 | We are wakners | spacedust | |
27/2/2018 16:48 | wossupusa - 12:00 - "PW HEMO to go blue and another 30% up before close? "You were saying . Do not try and take me on.! | pwhite73 | |
27/2/2018 13:26 | Rns released by Sar. Jeez what an rns. Pwhite any thoughts on Sar RNS? I don't think market has caught the news. | spacedust | |
27/2/2018 12:24 | courtesy of stiggy three major contracts in JUST three months! Hello!!!! Dr Jim Millen, CEO said: "We believe that the signing of agreements with three major pharmaceutical clients within the space of three months is a real sign of the confidence in our technology that is starting to build within the industry. Our aim now will be to develop longer-term relationships with these major companies and to secure further pre-clinical and clinical projects." So they've got their foot in the door with 3 Major Pharmas out of a client list of 58 And they've only just started rolling it out within those clients Merck went from £30k deals to €5 Why shouldn't Glaxo or whoever else also go from £30-70k initial deals to £500+k ? I think recent Industry and Regulatory approvals and validation of In Silico Clinical Trials (aka Biosimulation aka 'Modelling and Simulation') is causing a domino effect and Physiomics are going to be HUGE beneficiaries of this perfect storm. | the patient investor | |
27/2/2018 12:22 | If I was any calmer people would be checking if I had a pulse. | wossupsa | |
27/2/2018 12:11 | Outlook We are looking forward to a STRONG (my capitals) second half as a result of the Merck KGaA deal announced in November 2017 and the new contracts with major pharmaceutical clients announced in January and February. Honestly guys, what do you want more? a cheap stock with a great future no brainer | the patient investor | |
27/2/2018 12:08 | The Company now has clients in Europe and North America and is working on a range of projects including in immuno-oncology applications. For the first time in recent years the Company is seeking to expand the size of its technical team to increase its capacity to service new clients. i will repeat for the thickkos INCREASE ITS CAPACITY TO SERVICE NEW NEW NEW NEW CLIENTS! hello!! | the patient investor | |
27/2/2018 12:01 | PW, HEMO to go blue and add another 30% before close? | wossupsa | |
27/2/2018 11:58 | so, why merck paid us half a million? | the patient investor | |
27/2/2018 11:57 | The Company now has clients in Europe and North America and is working on a range of projects including in immuno-oncology applications. For the first time in recent years the Company is seeking to expand the size of its technical team to increase its capacity to service new clients. | the patient investor | |
27/2/2018 11:56 | Yes but you don't have any technology to sell. As per my previous posts you are using your technology to carry out research work. To sell it you require exclusive patents. I have been over this ground. | pwhite73 | |
27/2/2018 11:51 | I'd add that the speed with which new companies will buy our technology will increase exponentially, they called it the halo effect, we are not anymore a newbie trying to prove something. as said we have received the seal of approval from a giant drug firm and this is the best possible advert for future contracts. space, just be patient, it must hurt horribly, but please don't give up hope on your 60p stake | the patient investor | |
27/2/2018 11:47 | my point is that pharmas spend HUGE money and HUGE amount of time to develop a new drug. With this technology they will drastically reduce both those parameters and be able to take their drugs to the market sooner and more cost effectively. This product in my opinion must be of huge appeal to ALL drug companies, so our potential market is enormous. | the patient investor | |
27/2/2018 11:42 | Those who sold in the teens have made money. Those who didn't like me who did read the rns are nursing loses. What is your point? | spacedust | |
27/2/2018 11:39 | Last time I came across you tpi you were selling due to a lack of patience funnily enough. | wossupsa |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions